“…Ultrastructural localization using electron microscopy immunogold, photoaffinity-labeled receptors with [ 125 I]-DTLET and biochemical subcellular fractionation techniques reveal that the majority of DOPrs are localized predominantly to intracellular sites, with only a small subset of DOPrs found in association with neuronal plasma membranes throughout the central and peripheral nervous systems (Pasquini et al, 1992;Zerari et al, 1994;Arvidsson et al, 1995;Cheng et al, 1995Cheng et al, , 1997Elde et al, 1995;Zhang et al, 1998;PetajaRepo et al, 2000;Cahill et al, 2001b;Commons et al, 2001;Wang and Pickel, 2001;Petäjä-Repo et al, 2002Commons, 2003;Guan et al, 2005;Lucido et al, 2005;Gendron et al, 2006). The small number of plasma membrane-bound receptors is consistent with the observation that DOPr agonists have modest effects in modulating nociception and reward (Cahill et al, 2007;Pradhan et al, 2011); however, systemic administration of DOPr agonists such as SNC80 produces locomotor hyperactivity, anxiolytic effects, antidepressant effects, and absence seizures (Pradhan et al, 2011;Chu Sin Chung and Kieffer, 2013;Gendron et al, 2015).…”